Live Breaking News & Updates on Ose Immunotherapeutics Sa

Stay updated with breaking news from Ose immunotherapeutics sa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

OSE Immunotherapeutics SA: Four Poster Presentations at 2022 ASCO Annual Meeting Seite 1

07.06.2022 - Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) and its clinical partners GERCOR, ARCAGY-GINECO and the FoRT Foundation (Fondazione Ricerca Traslazionale), presented four posters featuring neoepitope specific . Seite 1 ....

Ose Immunotherapeutics , Ose Immunotherapeutics Sa ,

OSE Immunotherapeutics To Present at 'Immuno-Oncology Summit Europe' and at 'Tumor Myeloid-Directed Therapies Summit' In London and Boston

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , United Kingdom , City Of , Elise Chiffoleau , Thomas Guillot , Florence Portejoie , Guillaume Van Renterghem , Darren Opland , Nantes University Hospital , Lifesci Communications , Nantes University At Hospital , Veloxis Pharmaceuticals Inc , Boehringer Ingelheim , Oncology Summit Europe , Myeloid Directed Therapies Summit , Translational Immunology , Nantes University , Non Small Cell Lung Cancer , Veloxis Pharmaceuticals , Lifesci Advisors , Universal Registration Document , Ose Immunotherapeutics Sa , Globe Newswire ,

OSE Immunotherapeutics Announces New European Patent Granted Covering CLEC-1, Novel Myeloid Immune Checkpoint Target For Cancer Immunotherapy

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , Elise Chiffoleau , Nicolas Poirier , Dominique Costantini , Thomas Guillot , Florence Portejoie , Guillaume Van Renterghem , Darren Opland , Nantes University Hospital , European Patent Office , Nantes University At Hospital , Boehringer Ingelheim , Lifesci Communications , Veloxis Pharmaceuticals Inc , Chief Executive Officer , Chief Scientific Officer , Translational Immunology , Nantes University , Non Small Cell Lung Cancer , Veloxis Pharmaceuticals , Lifesci Advisors , Universal Registration Document , Globe Newswire , Ose Immunotherapeutics Sa ,

OSE Immunotherapeutics Announces the Appointment of Dominique Costantini as Interim CEO Following the Departure of Alexis Peyroles

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

Alexis Peyroles , Dominique Costantini , Nantes University Hospital , Boehringer Ingelheim , Chief Executive , Chief Executive Officer , Laurence De Schoulepnikoff , Chief Business Officer , Chief Operating Officer , Non Small Cell Lung Cancer , Expansion Phase , Universal Registration Document , Coronavirus Pandemic , Ose Immunotherapeutics Sa , Globe Newswire ,